Source: MarketScreener

Valneva: Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference

( Saint-Herblain (France), December 5, 2019 - Valneva SE ("Valneva"), announced today that its management team including Thomas Lingelbach, CEO, David Lawrence, CFO, and Franck Grimaud, CBO, will hold media, investor and partnering meetings during the 38th Annual J.P. Morgan Healthcare Conference, Jan. 12 - Jan. 16,...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue


Thomas Lingelbach's photo - President & CEO of Valneva

President & CEO

Thomas Lingelbach

CEO Approval Rating


Valneva is a biotechnology company that develops and commercializes vaccines for the treatment of infectious diseases.

Read more